Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
- Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Driving A High-Adherence LTFU Trial Without An EDC
Discover how our partnership with a client was able to deliver a ten-year long-term follow-up (LTFU) trial that delivered an over 90% adherence rate while keeping trial costs low by not using an EDC.
-
Demystifying AI In Clinical Trials
AI is revolutionizing clinical trials by improving efficiency and data quality, but success depends on strategy and oversight. Explore practical ways to integrate AI responsibly.
-
Electronic Hauser Diary For Parkinson's Clinical Trials
In honor of World Movement Disorders Day, we highlight advances in Parkinson’s disease care. At the 2024 MDS Congress, Signant presented research on electronic diaries for tracking PD patients' functional status.
-
Navigating The Next Wave Of Innovation In eCOA
Learn how the right eCOA system enables site efficiency and elevated data quality, ensuring trials run smoothly and deliver more reliable results.
-
The Future Of Clinical Trials Rests On A Unified CTMS Platform
Discover why a unified CTMS platform is the answer for managing both the clinical trial itself and the data it produces when it comes to poorly integrated clinical trial management systems (CTMS).
-
The Benefits Of Next-Generation SAAS Have Arrived
See how life science companies are using software as a service (SaaS) to bring new benefits to study startup, data collection, and more with this short blog.
-
Achieving Self Sufficiency In Data Collection For Optinose
Uncover how this specialty pharmaceutical company was able to gain control over its EDC environment by adopting a solution their team could use in-house.
-
Why Protocol‑Driven eSource Solves Data Capture For 80% Of Sites
Designing data capture around study protocols boosts data quality and real‑time visibility. Reducing transcription and aligning workflows helps teams improve compliance and speed decisions.
-
Case Study: Using Technology To Reduce Operational Burden In Clinical Research
The Beat AML® master trial is transforming treatment for people with acute myeloid leukemia (AML), already improving survival for patients enrolled in a Beat AML study vs. standard chemotherapy. Read this case study to learn how a proven EHR-to-EDC system has enabled the success of this impactful trial.
-
Real-World Data Vs. Real-World Evidence
Unearth the ways real-world data (RWD) and real-world evidence (RWE) in clinical R&D can be used to provide additional validation for new therapies and drugs regarding their efficacy, safety, and value.
FROM THE EDITOR
- Telehealth In Clinical Trials: What Sites And Patients Think
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
RECENT NEWSLETTERS
- 03.07.26 -- February's Best In Clinical Tech — AI, eTMF & More
- 03.05.26 -- Is Your Legacy EDC Holding Back AI In Clinical Trials?
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?